Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06688461Not ApplicableRecruiting

High Intensity Interval Training and Insulin Sensitivity in Type 2 Diabetes

Role: lead

NCT07264049Not ApplicableCompleted

Education and Community Engagement Through a Food Survey

Role: lead

NCT06425042Not ApplicableRecruiting

Nicotinamide Riboside Supplementation and Exercise Training to Promote Healthy Longevity

Role: lead

NCT06202794Not ApplicableUnknown

TENS for the Treatment of Pain and Respiratory Function Following Mastopexy With Augmentation

Role: lead

All 4 trials loaded